A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndrome

A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndrome

Summary: To investigate long COVID-19 syndrome (LCS) pathophysiology, we performed an exploratory study with blood plasma derived from three groups: 1) healthy vaccinated individuals without SARS-CoV-2 exposure; 2) asymptomatic recovered patients at least three months after SARS-CoV-2 infection and;...

Full description

Bibliographic Details
Main Authors: Johannes J. Kovarik, Andrea Bileck, Gerhard Hagn, Samuel M. Meier-Menches, Tobias Frey, Anna Kaempf, Marlene Hollenstein, Tarik Shoumariyeh, Lukas Skos, Birgit Reiter, Marlene C. Gerner, Andreas Spannbauer, Ena Hasimbegovic, Doreen Schmidl, Gerhard Garhöfer, Mariann Gyöngyösi, Klaus G. Schmetterer, Christopher Gerner
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:iScience
Subjects:
Immunology
immune response
omics
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004222019903

Internet

http://www.sciencedirect.com/science/article/pii/S2589004222019903

Similar Items